| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 09/30/1992 | EP0506628A2 Aminoacyl and oligopeptidyl derivatives of allopurinol exhibiting immunostimulatory activity, and pharmaceutical formulations containing these substances |
| 09/30/1992 | EP0505680A1 Octapeptide or heptapeptide derivatives, a process for preparing them as well as medicaments containing these compounds and the use of them |
| 09/30/1992 | EP0505497A1 Wound treatment employing biologically active peptides |
| 09/30/1992 | EP0505385A1 Anti-aggregatory peptides containing a mercaptan or sulfide moiety |
| 09/30/1992 | EP0307472B1 Immunogenic recombinant yeast expression product and method for purifying it |
| 09/29/1992 | WO1992017196A1 Anti-thrombotic peptides and pseudopeptides |
| 09/29/1992 | CA2107088A1 Anti-thrombotic peptides and pseudopeptides |
| 09/29/1992 | CA1308217C Substrate peptides |
| 09/26/1992 | WO1992016551A1 Small peptidic compounds useful for the treatment of glaucoma |
| 09/26/1992 | WO1992016548A1 Compositions which are immunologically crossreactive with antibodies and preparative methods therefor |
| 09/26/1992 | CA2106982A1 Compositions which are immunologically crossreactive with antibodies and preparative methods therefor |
| 09/26/1992 | CA2106858A1 Small peptidic compounds useful for the treatment of glaucoma |
| 09/23/1992 | EP0504760A1 Ciclosporin form for pulmonary administration |
| 09/23/1992 | EP0504335A1 A fibronectin binding peptide |
| 09/23/1992 | EP0504241A1 Proteins and nucleic acids |
| 09/23/1992 | EP0504168A1 Synthetic calcitonin peptides |
| 09/22/1992 | US5149781 Steroid/thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma |
| 09/22/1992 | US5149778 Viricides; enzyme inhibitors |
| 09/22/1992 | CA1307752C Immunoaffinity purification system |
| 09/19/1992 | WO1992016555A1 Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers |
| 09/19/1992 | CA2736076A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 09/19/1992 | CA2101918A1 Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers |
| 09/17/1992 | WO1992015609A1 Compositions and methods to inhibit the activation of active factor xiii |
| 09/17/1992 | WO1992015605A2 Inhibitors of human neutrophil elastase and human cathepsin g |
| 09/17/1992 | WO1992015330A1 Method for anti-lhrh immunoneutralization for ungelded male domestic animals and peptide therefor |
| 09/17/1992 | DE4205196A1 Inhibition of mycotoxin contamination of crops by Fusarium - by admin. of bacillus subtilis strain |
| 09/17/1992 | CA2105863A1 Compositions and methods to inhibit the activation of active factor xiii |
| 09/16/1992 | WO1992016219A1 Polypeptides derived from the human immunodeficiency virus endonuclease protein |
| 09/16/1992 | EP0503960A1 Cyclic lipopeptides having antibiotic activity |
| 09/16/1992 | EP0503301A2 Peptide derivatives and application thereof |
| 09/16/1992 | EP0502987A1 Acylated bradykinin antagonists and uses therefor. |
| 09/16/1992 | EP0502928A1 METHODS OF DETECTING COLLAGEN DEGRADATION -i(IN VIVO). |
| 09/16/1992 | CA2063018A1 Lipopeptide derivatives |
| 09/15/1992 | WO1992016627A1 Recombinant anticoccidial vaccine |
| 09/15/1992 | US5147441 Azospirillum nitrogen fixing bacteria, bacillus, phosphorous solubilizer |
| 09/15/1992 | CA2106093A1 Recombinant anticoccidial vaccine |
| 09/15/1992 | CA1307623C Method for synthesizing a peptide containing a non-peptide bond |
| 09/15/1992 | CA1307479C Diagnostic methods and systems for quantifying apo ai |
| 09/09/1992 | EP0502198A1 Novel polypeptide and anti-hiv drug prepared therefrom |
| 09/09/1992 | EP0502124A1 Peptides and antibodies that inhibit integrin-ligand binding |
| 09/09/1992 | EP0316322B1 Tetrapeptide inhibiting the proliferation cycle of haematopoietic strain cells, methods of production and applications thereof |
| 09/09/1992 | EP0180595B1 Method of inhibiting and inducing human platelet aggregation |
| 09/08/1992 | US5145951 Protected ologopeptides; treating aids |
| 09/08/1992 | US5145838 Peptide derivatives |
| 09/08/1992 | CA1307374C Peptides containing an aliphatic-aromatic ketone side chain |
| 09/03/1992 | WO1992014823A1 Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis |
| 09/03/1992 | WO1992014754A1 Process for the phosphorylation of insulin and product produced thereby |
| 09/03/1992 | WO1992014751A1 Peptides for treatment |
| 09/03/1992 | WO1992014750A1 Recombinant thrombin receptor and related pharmaceuticals |
| 09/03/1992 | CA2104394A1 Recombinant thrombin receptor and related pharmaceuticals |
| 09/02/1992 | EP0501882A2 Method of anti LHRH immunoneutralization of non-castrated male animals and peptide therefore |
| 09/02/1992 | EP0501821A2 Anti-thrombin polypeptides |
| 09/02/1992 | EP0501557A1 Peptides immunochemically reactive with antibodies directed against hepatitis Non-A, Non-B virus |
| 09/02/1992 | EP0500826A1 Apo ai polypeptides, antibodies, and immunoassays |
| 09/02/1992 | EP0500791A1 The design and construction of non-infectious human retroviral mutants deficient in genomic rna |
| 09/02/1992 | EP0500745A1 Metal-peptide compositions and cosmetic methods for stimulating hair growth |
| 09/02/1992 | EP0500734A1 Protein complexes having factor viii:c activity and production thereof |
| 09/02/1992 | EP0500695A1 GnRH ANALOGS |
| 09/02/1992 | EP0500685A1 Method to identify analyte-binding ligands |
| 09/02/1992 | CA2062097A1 Peptides immunochemically reactive with antibodies directed against hepatitis non-a, non-b virus |
| 09/01/1992 | US5143854 Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| 08/29/1992 | CA2061920A1 Anti-thrombin polypeptides |
| 08/27/1992 | WO1992014756A1 Therapeutically useful peptides and peptides fragments |
| 08/26/1992 | EP0500170A2 Cyclic hexapeptides having antibiotic activity |
| 08/26/1992 | EP0499625A1 Conglutinin fragments, their production and use |
| 08/26/1992 | EP0472658A4 Fusion proteins having an in vivo post-translational modification site and methods of manufacture and purification |
| 08/25/1992 | US5141851 Isolated farnesyl protein transferase enzyme |
| 08/20/1992 | WO1992014150A1 Monoclonal antibodies against receptor-induced binding sites |
| 08/20/1992 | WO1992013965A1 Method of immobilizing and crosslinking proteins and other molecules and uses thereof |
| 08/20/1992 | WO1992013952A1 Improved inhibitors of thrombin |
| 08/20/1992 | WO1992013949A1 Nucleotide sequences coding for alpha chain variable regions in human lymphocyte receptors and applications thereof |
| 08/20/1992 | WO1992013883A1 Lhrh antagonists |
| 08/20/1992 | WO1992013880A1 Novel peptide |
| 08/20/1992 | WO1992013879A1 Novel peptides with anticoagulatory effect |
| 08/20/1992 | WO1992013878A2 Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same |
| 08/20/1992 | WO1992013870A1 Human platelet-derived growth factor receptors |
| 08/20/1992 | WO1992013867A1 Domains of extracellular region of human platelet derived growth factor receptor polypeptides |
| 08/20/1992 | WO1992013572A1 TECHNETIUM-99m LABELED POLYPEPTIDES FOR IMAGING |
| 08/20/1992 | WO1992010514A3 Synthetic antigens for the detection of antibodies to hepatitis c virus |
| 08/20/1992 | CA2103893A1 Monoclonal antibodies against receptor-induced binding sites |
| 08/20/1992 | CA2103577A1 Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same |
| 08/20/1992 | CA2101632A1 Human platelet-derived growth factor receptors |
| 08/20/1992 | CA2079461A1 Lhrh antagonists |
| 08/20/1992 | CA2061432A1 Cyclic hexapeptide compounds |
| 08/19/1992 | EP0499162A2 GM-CSF inhibiting oligopeptides |
| 08/19/1992 | EP0499161A2 GM-CSF inhibiting antibodies |
| 08/19/1992 | EP0499003A1 Polypeptides and peptides, particularly recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnosis of tuberculosis |
| 08/19/1992 | EP0498941A2 Peptide skeletal muscle relaxants |
| 08/19/1992 | EP0340245B1 Substituted alkylamides of teicoplanin compounds |
| 08/19/1992 | EP0305401B1 Combinations having synergistic growth hormone releasing activity and methods for use thereof |
| 08/18/1992 | US5140103 Quanitative analysis of telopeptides crosslinked by hydroxylysyl pyridinoline(HP) or lysyl pyridinoline(LP) derived from bone collagen reabsorption |
| 08/18/1992 | US5140102 Controls intestinal fluid absorption |
| 08/18/1992 | US5140101 Antiviral antibiotic BU-4344V |
| 08/18/1992 | US5140009 Stable against proteolytic enzymes; anticarcinogenic agents; urogenital disorders |
| 08/18/1992 | CA1306582C Synthetic polypeptides for detecting mycobacterial infections |
| 08/18/1992 | CA1306581C Platelet binding inhibitors |
| 08/15/1992 | WO1992014755A1 A NOVEL INTEGRIN SPECIFICITY FOR THE HIV Tat PROTEIN |
| 08/15/1992 | CA2101919A1 Integrin specificity for the hiv tat protein |
| 08/14/1992 | CA2054627A1 Polypeptide skeletal muscle relaxants |
| 08/13/1992 | WO1992013881A1 Peptides |